Compounds derived from 1 - [3 - (1h-pyrazol-4-yl) - yl] - 6 - quinoxalin 2,3,4,5 - tetrahydro - (1H - 1.4 - benzodiazepine / benzodiazocina), modulators of FGFR； Preparation Process； Pharmaceutical Composition and its use for the Treatment or prophylaxis of cancer
VERMEULEN, Wim,HOSTYN, Steven Anna,CUYCKENS, Filip Albert Celine,JONES, Russell Mark,BROGGINI, Diego Fernando Domenico
申请号：
CL2016002382
公开号：
CL2016002382A1
申请日:
2016.09.22
申请国别(地区):
CL
年份:
2017
代理人:
摘要：
Compounds derived from 1 - [3 - (1h-pyrazol-4-yl) - yl] - 6 - quinoxalin 2,3,4,5 - tetrahydro - (1H - 1.4 - benzodiazepine / benzodiazocina), modulators of FGFR； Preparation Process； Pharmaceutical Composition and its use for the Treatment or prophylaxis of cancer.Compuestos derivados de 1-[3-(1H-pirazol-4-il)quinoxalin-6-il]-2,3,4,5-tetrahidro-1H-1,4-(benzodiazepina/benzodiazocina), moduladores de FGFR； proceso de preparación； composición farmacéutica； y su uso para el tratamiento o la profilaxis del cáncer.
